Humanized mouse models for preclinical evaluation of novel immune cell therapies, checkpoint inhibitors, and immune cell engagers

被引：0
|
作者：
Stecklum, Maria [1 ]
Wulf-Goldenberg, Annika [1 ]
Brzezicha, Bernadette [1 ]
Walther, Wolfgang [1 ]
Hoffmann, Jens [1 ]
机构：
[1] EPO GmbH, Berlin, Germany
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1650
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Donor selection strategies to optimize humanized mouse models for the evaluation of T cell engagers.
    Cheng, Liqing
    Chen, Jane
    Yu, Qunyan
    Malkova, Natalia
    Cortez-Retamozo, Virna F.
    Sun, Fangxian
    Sidhu, Sukhvinder
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [12] CD3 HUMANIZED MOUSE MODELS AS VALIDATED TOOLS TO ASSESS IMMUNE-RELATED ADVERSE EVENTS OF T CELL ENGAGERS
    Martin-Jeantet, Perrine
    Martin, Gaelle
    Pappalardo, Angela
    Renart-depontieu, Florence
    Isnard-Petit, Patricia
    Cherifi, Yacine
    Sonego, Fabiane
    Thiam, Kader
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A157 - A157
  • [13] Evaluation of fruquintinib, a potent and selective oral VEGFR inhibitor, in combination with targeted therapies or immune checkpoint inhibitors in preclinical tumor models
    Ren, Yongxin
    Sun, Qiaoling
    Long, Jingwen
    Fan, Shiming
    Tang, Renxiang
    Zhang, Wei
    Ge, Xuelei
    Tang, Jianxing
    Wang, Linfang
    Shi, Dongxia
    Chen, Hongbo
    Cheng, Min
    Qing, Weiguo
    Su, Weiguo
    [J]. CANCER RESEARCH, 2017, 77
  • [14] Are immune checkpoint combination therapies for intermediate and poor risk renal cell carcinoma better than immune checkpoint inhibitors combined with kinase inhibitors?
    McDermott, David F.
    Atkins, Michael B.
    [J]. LANCET ONCOLOGY, 2021, 22 (05): : 593 - 594
  • [15] Immune checkpoint inhibitors in renal cell carcinoma
    Ross, Kirsty
    Jones, Rob J.
    [J]. CLINICAL SCIENCE, 2017, 131 (21) : 2627 - 2642
  • [16] Immune Checkpoint Inhibitors as Novel Targets for Renal Cell Carcinoma Therapeutics
    Bailey, Alexandra
    McDermott, David F.
    [J]. CANCER JOURNAL, 2013, 19 (04): : 348 - 352
  • [17] Novel Cell and Immune Engagers in Optimizing Tumor- Specific in
    Janakiram, Murali
    Arora, Nivedita
    Bachanova, Veronika
    Miller, Jeffrey S.
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (02): : 61 - 69
  • [18] Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined Therapies
    Zanotta, Serena
    Galati, Domenico
    De Filippi, Rosaria
    Pinto, Antonio
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [19] Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors
    Kim, Hye Ryeon
    Kang, Jung Hun
    Kim, Sung Hyun
    Kim, Seung Tae
    Kim, Ilhwan
    Min, Young Joo
    Shin, Seong Hoon
    Oh, Sung Yong
    Lee, Gyeong-Won
    Lee, Ji Hyun
    Ji, Jun Ho
    Huh, Seok Jae
    Lee, Suee
    [J]. CANCERS, 2022, 14 (14)
  • [20] Cytokines and Immune Cell Profiling in AKI Associated With Immune Checkpoint Inhibitors
    Farooqui, Naba
    Ahsan, Eram
    Vaughan, Lisa E.
    Taner, Timucin
    Leung, Nelson
    Alexander, Mariam P.
    Herrmann, Sandra
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 643 - 643
12345